Insider buying
~$117K76K sh @ $1.53
Their largest buy since 2025Traded Nov 18 · filed 2 days later
Since the trade
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 4 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider buying
Their largest buy since 2025Traded Nov 18 · filed 2 days later
Since the trade
Bought 85% below the 52-week high, RSI 34, 55% under its 200-day average, 39 points behind the S&P 500 over 3 months
The CEO of Cervomed paid $117K out of pocket for Cervomed shares. It was the first purchase in 12 months. Shares held went up 5% with this purchase.
Lately at Cervomed: the stock fell 21% in one session on Oct 29 around a company release; it reported its results on Nov 9; the stock is down 38% in 30 days.
Insider buying
First insider buy since Mar 2025Traded Nov 19 · filed 1 day later
Since the trade −11.8% · S&P 500 −3.6% · to Nov 20
Bought 88% below the 52-week high, RSI 51, 57% under its 200-day average, 40 points behind the S&P 500 over 3 months
The CEO of Modular Medical paid $20K out of pocket for Modular Medical shares. It was the first purchase in 20 months. Shares held went up 71% with this purchase.
Lately at Modular Medical: it changed a top executive or board member on Oct 28; the stock is down 15% in 30 days.
Insider buying
Open-market purchases, traded Nov 19, 2026. Each amount is that person's own.
Lately at Aeon Biopharma: it reported its results on Nov 16; the stock is down 49% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
First insider buy since Apr 2023Traded Nov 20 · filed the same day
Bought 17% below the 52-week high, RSI 36, 7% under its 200-day average
Home Bancorp's Chief Risk Officer paid $315K out of pocket for Home Bancorp shares. Shares held went up 255% with this purchase.
Lately at Home Bancorp: it changed a top executive or board member on Oct 19.
Insider buying
Their first buy on recordTraded Nov 17 · filed 3 days later
Since the trade −5.3% · S&P 500 −5.8% · to Nov 20
Bought within 1% of the 52-week low, RSI 34, 27% under its 200-day average, 24 points behind the S&P 500 over 3 months
The CEO of Legend Biotech paid $163K out of pocket for Legend Biotech shares. 1 other person at Legend Biotech bought some too, in the same month.
Lately at Legend Biotech: the stock fell 16% in one session on Nov 10 with press coverage; the stock is down 18% in 30 days; insiders made 3 purchases ($10K+) and 1 large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Their first buy on recordTraded Nov 18 · filed 2 days later
Since the trade −22.3% · S&P 500 −5.5% · to Nov 20
A Suncrete director paid $113K out of pocket for Suncrete shares. 6 other people at Suncrete bought some too, in the same month.
Lately at Suncrete: the stock rose 24% in one session on Nov 18 with press coverage; it reported its results on Nov 13; the stock is down 38% in 30 days.
Insider buying
4 insiders in a week, a first since 2006Traded Nov 18 · filed 2 days later
Since the trade +17.7% · S&P 500 −5.5% · to Nov 20
The CEO of Filana Therapeutics paid $23K out of pocket for Filana Therapeutics shares. 3 other people at Filana Therapeutics bought some too, in the same month.
Lately at Filana Therapeutics: it changed a top executive or board member on Nov 12; the stock is 69% below its 12-month high; insiders made 7 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Their first buy on recordTraded Nov 18 · filed 2 days later
Since the trade +6.9% · S&P 500 −5.5% · to Nov 20
An Once Upon A Farm, Pbc director paid $94K out of pocket for Once Upon A Farm, Pbc shares. 4 other people at Once Upon A Farm, Pbc bought some too, in the same month.
Lately at Once Upon A Farm, Pbc: the stock rose 21% in one session on Nov 16 with press coverage; it reported its results on Nov 12; the stock is down 24% in 30 days.
Insider buying
First insider buy since Oct 2023Traded Nov 18 · filed 2 days later
Since the trade −10.2% · S&P 500 −5.5% · to Nov 20
A Nomad Power Solutions director paid $42K out of pocket for Nomad Power Solutions shares. 1 other person at Nomad Power Solutions bought some too, in the same month. Shares held went up 38% with this purchase.
Lately at Nomad Power Solutions: the stock fell 21% in one session on Nov 19 with press coverage; it changed a top executive or board member on Nov 10; the stock is down 27% in 30 days.
Insider buying
Traded Nov 19 · filed 1 day later
Since the trade +1.2% · S&P 500 −3.6% · to Nov 20
Bought 42% below the 52-week high, RSI 22, 11% above its 200-day average, 18 points behind the S&P 500 over 3 months
The CEO of Atlassian paid $383K out of pocket for Atlassian shares.
Lately at Atlassian: the stock fell 16% in one session on Nov 6 around a company release; it changed a top executive or board member on Nov 5; the stock is down 40% in 30 days.
Insider buying
Traded Nov 18 · filed 2 days later
Since the trade −8.5% · S&P 500 −5.5% · to Nov 20
Bought at the 52-week low, RSI 28, 47% under its 200-day average, 46 points behind the S&P 500 over 3 months
A Contango Silver & Gold director paid $97K out of pocket for Contango Silver & Gold shares. 2 other people at Contango Silver & Gold bought some too, in the same month.
Lately at Contango Silver & Gold: the stock rose 11% in one session on Nov 4; it signed an important agreement on Nov 13; the stock is down 37% in 30 days.
Traded Nov 18 – Nov 19, 2026 · largest single transaction ~$938K
Lately at San Juan Basin Royalty Trust: the stock rose 17% in one session on Nov 10; it reported its results on Nov 19; the stock is up 29% in 30 days.
Nov 19, 2026~$938K · 188K sh @ $4.98
DetailsOfficial recordNov 18, 2026~$888K · 180K sh @ $4.94
DetailsOfficial recordInsider buying
First buy since 2024Traded Nov 20 · filed the same day
Bought at the 52-week low, RSI 32, 25% under its 200-day average, 16 points behind the S&P 500 over 3 months
The CFO of Flagstar Bank paid $50K out of pocket for Flagstar Bank shares. 2 other people at Flagstar Bank bought some too, in the same month.
Lately at Flagstar Bank: it reported its results on Oct 23; the stock is down 10% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 19 · filed 1 day later
Since the trade +9.9% · S&P 500 −3.6% · to Nov 20
Bought 62% below the 52-week high, RSI 64, 15% under its 200-day average, 61 points ahead of the S&P 500 over 3 months
The CEO of Sagtec Global paid $268K out of pocket for Sagtec Global shares.
Lately at Sagtec Global: the stock is up 96% in 30 days.
Insider buying
First insider buy since Sep 2024Traded Nov 18 · filed 2 days later
Since the trade −11.7% · S&P 500 −5.5% · to Nov 20
Bought within 1% of the 52-week low, RSI 22, 54% under its 200-day average, 62 points behind the S&P 500 over 3 months
An Airjoule Technologies director paid $50K out of pocket for Airjoule Technologies shares. It was the first purchase in over a year. Shares held went up 49% with this purchase.
Lately at Airjoule Technologies: the stock fell 14% in one session on Nov 17 around a company release; it changed a top executive or board member on Nov 16; the stock is down 49% in 30 days.
Insider buying
Traded Nov 19 · filed 1 day later
Since the trade +1.1% · S&P 500 −3.6% · to Nov 20
Bought 13% below the 52-week high, RSI 36, 3% above its 200-day average
An Elevance Health director paid $384K out of pocket for Elevance Health shares. Shares held went up 9% with this purchase.
Lately at Elevance Health: it reported its results on Oct 21; the stock is down 9% in 30 days; insiders made 1 purchase ($10K+) and 6 large sales ($250K+, not pre-arranged) in 90 days.
Insider buying
First buy since 2024Traded Nov 19 · filed 1 day later
Since the trade −0.2% · S&P 500 −3.6% · to Nov 20
Bought 18% below the 52-week high, RSI 41, 1% above its 200-day average
A Bank of the James Financial director paid $50K out of pocket for Bank of the James Financial shares. 3 other people at Bank of the James Financial bought some too, in the same month.
Lately at Bank of the James Financial Group: the stock fell 18% in one session on Oct 29 around a Form 8-K; it reported its results on Oct 30; the stock is down 11% in 30 days.
Insider buying
Their largest buy since 2024Traded Nov 19 · filed 1 day later
Since the trade −0.5% · S&P 500 −3.6% · to Nov 20
Bought 14% below the 52-week high, RSI 30, 4% under its 200-day average
A Community West Bancshares director paid $25K out of pocket for Community West Bancshares shares. 2 other people at Community West Bancshares bought some too, in the same month. It was the first purchase in 19 months.
Lately at Community West Bancshares: it reported its results on Oct 22; the stock is down 6% in 30 days; insiders made 4 purchases ($10K+) and 1 large sale ($250K+, not pre-arranged) in 90 days.